Industry

EsoGuard test volume increased 60% for quarter and over 300% annually CLIA-Certified LucidDx Labs fully operational and billing as an independent entity Conference call to be held today at 4:30 PM EDT NEW YORK–(BUSINESS WIRE)–$LUCD #investing—Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”, the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed … [Read more…]

CARLSBAD, Calif.–(BUSINESS WIRE)–$RMED #Ra_Medical—Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) reports financial results for the three and six months ended June 30, 2022 and provides a business update. “We are continuing to pursue a potential merger with a privately held company, Catheter Precision, Inc., (“Catheter Precision”) which would give our … [Read more…]

AUSTIN, Texas & LONDON–(BUSINESS WIRE)–Babylon Holdings Limited (NYSE: BBLN) (“Babylon” or the “Company”), one of the world’s fastest-growing digital healthcare companies, today announced that it is not engaged in nor has it had contact or discussions with any potential acquirer. The Company is actively working with the staff of the NYSE to resume trading as … [Read more…]

265% growth in unit sales through direct-to-consumer channels, 97% overall revenue growth vs. Q2 2021 SAN FRANCISCO–(BUSINESS WIRE)–$TIVC #healthcare—Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced its financial results for the quarter ended June 30, 2022. Jennifer Ernst, CEO of Tivic Health … [Read more…]

BOSTON–(BUSINESS WIRE)–Fish & Richardson secured a significant victory for Exela Pharma Sciences, LLC, the maker of ELCYS®, in patent infringement litigation against Eton Pharmaceuticals, Inc., over its intent to produce a generic version of Exela’s patented ELCYS® product. ELCYS® is the only FDA-approved cysteine hydrochloride injection on the market for use as an additive to … [Read more…]

SALT LAKE CITY–(BUSINESS WIRE)–#nasal–Xlear has filed an Amended Answer in response to the U.S. Government’s lawsuit against the company. According to Nathan Jones, Xlear’s CEO, the Amended Answer serves three main purposes: First, it provides the Court with still more data that supports the statements Xlear made that nasal hygiene is an additional layer of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Patient Monitoring Equipment Market Report Suite – Global – 2022-2028 – MedSuite” report has been added to ResearchAndMarkets.com’s offering. In 2021, the global patient monitoring market size reached an approximate value of $9.8 billion, with the wireless ambulatory telemetry market showing the fastest growth and demand. In spite of the COVID-19 pandemic, the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Minimally Invasive Spine Surgery Market Report Suite – Global – 2022-2028 – MedSuite” report has been added to ResearchAndMarkets.com’s offering. The global minimally invasive spinal implant market was valued at $3.7 million in 2021. Over the forecast period, this is expected to increase at a CAGR of 8.4% to reach $6.4 million. The … [Read more…]

PHILADELPHIA–(BUSINESS WIRE)–The American College of Physicians (ACP) is launching a new branding campaign designed to articulate the vital role and value of internal medicine physicians, and the breadth, depth, and diversity of the Internal Medicine profession. The new multichannel campaign showcases the leadership and impact of internal medicine physicians serving in many roles and settings … [Read more…]

Company to Leverage its Long-term Leadership in Interoperability to Facilitate Open Exchange of Healthcare Data ATLANTA–(BUSINESS WIRE)–$NXGN #Interoperability–NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced that it will apply to become a Qualified Health Information Network (QHIN) under the Trusted Exchange Framework and Common Agreement (TEFCA) in … [Read more…]